Web17 mrt. 2024 · Sage Therapeutics is part of the Manufacturing industry, and located in Massachusetts, United States. Sage Therapeutics Location 215 1st St, Cambridge, Massachusetts, 02142, United States Description Industry Pharmaceuticals Healthcare Discover more about Sage Therapeutics Saritha Talapala Work Experience and Education WebSee the company profile for Sage Therapeutics, Inc. (SAGE) including business summary, industry/sector information, number of employees, business summary, ... Dr. Jim Doherty Ph.D.
Sage Therapeutics Announces Third Quarter 2024 Financial …
Web30 sep. 2024 · Jim Doherty, Ph.D., assumed the role of Chief Development Officer. Jim will continue to drive expansion and acceleration of Sage’s development programs and lead the Research and Development Leadership Team. ... contact Sage Therapeutics, Inc. at 1-844-4-SAGERX (1-844-472-4379) ... Web24 feb. 2024 · Sage Therapeutics, Inc. ( NASDAQ: SAGE) Q4 2024 Earnings Conference Call February 24, 2024 8:00 AM ET Company Participants Helen Rubinstein - Director, IR Barry Greene - CEO Jim Doherty -... think recruitment
Our Team - Sage Therapeutics
Web15 sep. 2024 · SAGE-718, Sage’s first-in-class NMDA receptor PAM and lead neuropsychiatric drug candidate, is in development as a potential oral therapy for cognitive disorders associated with NMDA receptor dysfunction, potentially including Huntington’s disease (HD), Parkinson’s disease (PD) and Alzheimer’s disease (AD). Web16 sep. 2024 · Cecchi, Marco and Adachi, Megumi and Basile, Anthony and Buhl, Derek and Chadchankar, Heramb and Christensen, Søren and Christian, Edward and Doherty, Jim and Fadem, KC and Farley, Brandon and Forman, Mark and Honda, Sokichi and Johannesen, Jason and Kinon, Bruce and Klamer, Daniel and Michael, Marino and … Web8 mrt. 2024 · Sage’s chief development officer Jim Doherty told Endpoints News that before this morning, the company had not heard from the agency whether an adcomm … think recruitment goulburn